Single injection of Alnylam's RNAi therapy reduces Alzheimer's-linked proteins by 65% for six months
A single injection of an experimental treatment for Alzheimer’s reduced levels of proteins linked to the disease by roughly two-thirds for six months, Alnylam announced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
